Editorial 無益な細胞療法 2017年4月1日 Nature Biotechnology 35, 4 doi: 10.1038/nbt.3857 Should a cell therapy for heart disease with scant evidence of efficacy continue to be tested in humans? Full text PDF 目次へ戻る
